PYRAMID and LYM2034: Targeted randomized phase II studies of bortezomib with or without immunochemotherapy in newly diagnosed nongerminal center B-cell-like (GCB) diffuse large B-cell lymphoma (DLBCL), including rapid prospective non-GCB subtype identification.
Date
2011Author
Flinn, I. W.
Leonard, J.
Reeves, J.
Ferhanoglu, B.
Doner, K. T.
Eom, H.
Raposo, J.
Chowhan, N. M.
Suh, C.
Noga, S.
Tumyan, G.
Aung, S.
Hajdenberg, J.
Ulrich, B. K.
Pendergrass, K. B.
Mulligan, G.
Rizo, A.
Kussick, S.
Offner, F.
Metadata
Show full item recordCollections
- Makale [92796]